Global Neuromodulation Devices Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Neuromodulation Devices market size was valued at US$ million in 2023. With growing demand in downstream market, the Neuromodulation Devices is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Neuromodulation Devices market. Neuromodulation Devices are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neuromodulation Devices. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neuromodulation Devices market.
Neuromodulation devices are medical tools used to modulate the activity of the nervous system. They operate by delivering electrical, magnetic, or pharmaceutical stimuli to specific neural targets in order to alleviate symptoms of neurological and psychiatric disorders, manage pain, or enhance cognitive functions. These devices are designed to offer alternative and effective treatment options for patients who have not responded well to conventional therapies or medications.
Common types of neuromodulation devices include:
1. Deep Brain Stimulation (DBS) Devices: DBS devices involve the implantation of electrodes within specific areas of the brain to deliver electrical stimulation. They are utilized to treat conditions such as Parkinson's disease, essential tremor, and dystonia.
2. Spinal Cord Stimulation (SCS) Devices: SCS devices send electrical impulses to the spinal cord to alleviate chronic pain, particularly in cases where other treatments have not been effective.
3. Transcranial Magnetic Stimulation (TMS) Devices: TMS devices use magnetic fields to stimulate specific areas of the brain and are employed as an alternative treatment for depression and certain psychiatric disorders.
4. Sacral Neuromodulation Devices: These devices are used to manage urinary incontinence, urinary retention, and fecal incontinence by delivering electrical stimulation to the sacral nerves.
Neuromodulation devices strive to improve the quality of life for patients suffering from various neurological and psychiatric conditions. They are developed based on ongoing research and technological advancements in the fields of neuroscience and medical engineering. However, it is crucial for physicians and patients to thoroughly evaluate the potential benefits and risks associated with the use of these devices to ensure safe and effective treatment.
Key Features:
The report on Neuromodulation Devices market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neuromodulation Devices market. It may include historical data, market segmentation by Type (e.g., Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neuromodulation Devices market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neuromodulation Devices market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neuromodulation Devices industry. This include advancements in Neuromodulation Devices technology, Neuromodulation Devices new entrants, Neuromodulation Devices new investment, and other innovations that are shaping the future of Neuromodulation Devices.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neuromodulation Devices market. It includes factors influencing customer ' purchasing decisions, preferences for Neuromodulation Devices product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neuromodulation Devices market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neuromodulation Devices market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neuromodulation Devices market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neuromodulation Devices industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neuromodulation Devices market.
Market Segmentation:
Neuromodulation Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Neuromodulation Devices market?
What factors are driving Neuromodulation Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neuromodulation Devices market opportunities vary by end market size?
How does Neuromodulation Devices break out type, application?
According to our LPI (LP Information) latest study, the global Neuromodulation Devices market size was valued at US$ million in 2023. With growing demand in downstream market, the Neuromodulation Devices is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Neuromodulation Devices market. Neuromodulation Devices are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neuromodulation Devices. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neuromodulation Devices market.
Neuromodulation devices are medical tools used to modulate the activity of the nervous system. They operate by delivering electrical, magnetic, or pharmaceutical stimuli to specific neural targets in order to alleviate symptoms of neurological and psychiatric disorders, manage pain, or enhance cognitive functions. These devices are designed to offer alternative and effective treatment options for patients who have not responded well to conventional therapies or medications.
Common types of neuromodulation devices include:
1. Deep Brain Stimulation (DBS) Devices: DBS devices involve the implantation of electrodes within specific areas of the brain to deliver electrical stimulation. They are utilized to treat conditions such as Parkinson's disease, essential tremor, and dystonia.
2. Spinal Cord Stimulation (SCS) Devices: SCS devices send electrical impulses to the spinal cord to alleviate chronic pain, particularly in cases where other treatments have not been effective.
3. Transcranial Magnetic Stimulation (TMS) Devices: TMS devices use magnetic fields to stimulate specific areas of the brain and are employed as an alternative treatment for depression and certain psychiatric disorders.
4. Sacral Neuromodulation Devices: These devices are used to manage urinary incontinence, urinary retention, and fecal incontinence by delivering electrical stimulation to the sacral nerves.
Neuromodulation devices strive to improve the quality of life for patients suffering from various neurological and psychiatric conditions. They are developed based on ongoing research and technological advancements in the fields of neuroscience and medical engineering. However, it is crucial for physicians and patients to thoroughly evaluate the potential benefits and risks associated with the use of these devices to ensure safe and effective treatment.
Key Features:
The report on Neuromodulation Devices market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neuromodulation Devices market. It may include historical data, market segmentation by Type (e.g., Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neuromodulation Devices market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neuromodulation Devices market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neuromodulation Devices industry. This include advancements in Neuromodulation Devices technology, Neuromodulation Devices new entrants, Neuromodulation Devices new investment, and other innovations that are shaping the future of Neuromodulation Devices.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neuromodulation Devices market. It includes factors influencing customer ' purchasing decisions, preferences for Neuromodulation Devices product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neuromodulation Devices market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neuromodulation Devices market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neuromodulation Devices market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neuromodulation Devices industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neuromodulation Devices market.
Market Segmentation:
Neuromodulation Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Deep Brain Stimulation (DBS)
- Spinal Cord Stimulation (SCS)
- Vagus Nerve Stimulation (VNS)
- Sacral Nerve Stimulation (SNS)
- Gastric Electrical Stimulation (GES)
- Pain Management
- Parkinson’s Disease
- Urinary and Fecal Incontinence
- Epilepsy
- Gastroparesis
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic
- Boston Scientific
- Abbott
- LivaNova
- Nevro
- NeuroPace
- Beijing Pins
- Synapse Biomedical
What is the 10-year outlook for the global Neuromodulation Devices market?
What factors are driving Neuromodulation Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neuromodulation Devices market opportunities vary by end market size?
How does Neuromodulation Devices break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuromodulation Devices Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Neuromodulation Devices by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Neuromodulation Devices by Country/Region, 2019, 2023 & 2030
2.2 Neuromodulation Devices Segment by Type
2.2.1 Deep Brain Stimulation (DBS)
2.2.2 Spinal Cord Stimulation (SCS)
2.2.3 Vagus Nerve Stimulation (VNS)
2.2.4 Sacral Nerve Stimulation (SNS)
2.2.5 Gastric Electrical Stimulation (GES)
2.3 Neuromodulation Devices Sales by Type
2.3.1 Global Neuromodulation Devices Sales Market Share by Type (2019-2024)
2.3.2 Global Neuromodulation Devices Revenue and Market Share by Type (2019-2024)
2.3.3 Global Neuromodulation Devices Sale Price by Type (2019-2024)
2.4 Neuromodulation Devices Segment by Application
2.4.1 Pain Management
2.4.2 Parkinson’s Disease
2.4.3 Urinary and Fecal Incontinence
2.4.4 Epilepsy
2.4.5 Gastroparesis
2.4.6 Other
2.5 Neuromodulation Devices Sales by Application
2.5.1 Global Neuromodulation Devices Sale Market Share by Application (2019-2024)
2.5.2 Global Neuromodulation Devices Revenue and Market Share by Application (2019-2024)
2.5.3 Global Neuromodulation Devices Sale Price by Application (2019-2024)
3 GLOBAL NEUROMODULATION DEVICES BY COMPANY
3.1 Global Neuromodulation Devices Breakdown Data by Company
3.1.1 Global Neuromodulation Devices Annual Sales by Company (2019-2024)
3.1.2 Global Neuromodulation Devices Sales Market Share by Company (2019-2024)
3.2 Global Neuromodulation Devices Annual Revenue by Company (2019-2024)
3.2.1 Global Neuromodulation Devices Revenue by Company (2019-2024)
3.2.2 Global Neuromodulation Devices Revenue Market Share by Company (2019-2024)
3.3 Global Neuromodulation Devices Sale Price by Company
3.4 Key Manufacturers Neuromodulation Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neuromodulation Devices Product Location Distribution
3.4.2 Players Neuromodulation Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NEUROMODULATION DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Neuromodulation Devices Market Size by Geographic Region (2019-2024)
4.1.1 Global Neuromodulation Devices Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Neuromodulation Devices Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Neuromodulation Devices Market Size by Country/Region (2019-2024)
4.2.1 Global Neuromodulation Devices Annual Sales by Country/Region (2019-2024)
4.2.2 Global Neuromodulation Devices Annual Revenue by Country/Region (2019-2024)
4.3 Americas Neuromodulation Devices Sales Growth
4.4 APAC Neuromodulation Devices Sales Growth
4.5 Europe Neuromodulation Devices Sales Growth
4.6 Middle East & Africa Neuromodulation Devices Sales Growth
5 AMERICAS
5.1 Americas Neuromodulation Devices Sales by Country
5.1.1 Americas Neuromodulation Devices Sales by Country (2019-2024)
5.1.2 Americas Neuromodulation Devices Revenue by Country (2019-2024)
5.2 Americas Neuromodulation Devices Sales by Type
5.3 Americas Neuromodulation Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuromodulation Devices Sales by Region
6.1.1 APAC Neuromodulation Devices Sales by Region (2019-2024)
6.1.2 APAC Neuromodulation Devices Revenue by Region (2019-2024)
6.2 APAC Neuromodulation Devices Sales by Type
6.3 APAC Neuromodulation Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neuromodulation Devices by Country
7.1.1 Europe Neuromodulation Devices Sales by Country (2019-2024)
7.1.2 Europe Neuromodulation Devices Revenue by Country (2019-2024)
7.2 Europe Neuromodulation Devices Sales by Type
7.3 Europe Neuromodulation Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuromodulation Devices by Country
8.1.1 Middle East & Africa Neuromodulation Devices Sales by Country (2019-2024)
8.1.2 Middle East & Africa Neuromodulation Devices Revenue by Country (2019-2024)
8.2 Middle East & Africa Neuromodulation Devices Sales by Type
8.3 Middle East & Africa Neuromodulation Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neuromodulation Devices
10.3 Manufacturing Process Analysis of Neuromodulation Devices
10.4 Industry Chain Structure of Neuromodulation Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neuromodulation Devices Distributors
11.3 Neuromodulation Devices Customer
12 WORLD FORECAST REVIEW FOR NEUROMODULATION DEVICES BY GEOGRAPHIC REGION
12.1 Global Neuromodulation Devices Market Size Forecast by Region
12.1.1 Global Neuromodulation Devices Forecast by Region (2025-2030)
12.1.2 Global Neuromodulation Devices Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neuromodulation Devices Forecast by Type
12.7 Global Neuromodulation Devices Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Neuromodulation Devices Product Portfolios and Specifications
13.1.3 Medtronic Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Neuromodulation Devices Product Portfolios and Specifications
13.2.3 Boston Scientific Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Neuromodulation Devices Product Portfolios and Specifications
13.3.3 Abbott Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 LivaNova
13.4.1 LivaNova Company Information
13.4.2 LivaNova Neuromodulation Devices Product Portfolios and Specifications
13.4.3 LivaNova Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 LivaNova Main Business Overview
13.4.5 LivaNova Latest Developments
13.5 Nevro
13.5.1 Nevro Company Information
13.5.2 Nevro Neuromodulation Devices Product Portfolios and Specifications
13.5.3 Nevro Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Nevro Main Business Overview
13.5.5 Nevro Latest Developments
13.6 NeuroPace
13.6.1 NeuroPace Company Information
13.6.2 NeuroPace Neuromodulation Devices Product Portfolios and Specifications
13.6.3 NeuroPace Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 NeuroPace Main Business Overview
13.6.5 NeuroPace Latest Developments
13.7 Beijing Pins
13.7.1 Beijing Pins Company Information
13.7.2 Beijing Pins Neuromodulation Devices Product Portfolios and Specifications
13.7.3 Beijing Pins Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Beijing Pins Main Business Overview
13.7.5 Beijing Pins Latest Developments
13.8 Synapse Biomedical
13.8.1 Synapse Biomedical Company Information
13.8.2 Synapse Biomedical Neuromodulation Devices Product Portfolios and Specifications
13.8.3 Synapse Biomedical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Synapse Biomedical Main Business Overview
13.8.5 Synapse Biomedical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuromodulation Devices Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Neuromodulation Devices by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Neuromodulation Devices by Country/Region, 2019, 2023 & 2030
2.2 Neuromodulation Devices Segment by Type
2.2.1 Deep Brain Stimulation (DBS)
2.2.2 Spinal Cord Stimulation (SCS)
2.2.3 Vagus Nerve Stimulation (VNS)
2.2.4 Sacral Nerve Stimulation (SNS)
2.2.5 Gastric Electrical Stimulation (GES)
2.3 Neuromodulation Devices Sales by Type
2.3.1 Global Neuromodulation Devices Sales Market Share by Type (2019-2024)
2.3.2 Global Neuromodulation Devices Revenue and Market Share by Type (2019-2024)
2.3.3 Global Neuromodulation Devices Sale Price by Type (2019-2024)
2.4 Neuromodulation Devices Segment by Application
2.4.1 Pain Management
2.4.2 Parkinson’s Disease
2.4.3 Urinary and Fecal Incontinence
2.4.4 Epilepsy
2.4.5 Gastroparesis
2.4.6 Other
2.5 Neuromodulation Devices Sales by Application
2.5.1 Global Neuromodulation Devices Sale Market Share by Application (2019-2024)
2.5.2 Global Neuromodulation Devices Revenue and Market Share by Application (2019-2024)
2.5.3 Global Neuromodulation Devices Sale Price by Application (2019-2024)
3 GLOBAL NEUROMODULATION DEVICES BY COMPANY
3.1 Global Neuromodulation Devices Breakdown Data by Company
3.1.1 Global Neuromodulation Devices Annual Sales by Company (2019-2024)
3.1.2 Global Neuromodulation Devices Sales Market Share by Company (2019-2024)
3.2 Global Neuromodulation Devices Annual Revenue by Company (2019-2024)
3.2.1 Global Neuromodulation Devices Revenue by Company (2019-2024)
3.2.2 Global Neuromodulation Devices Revenue Market Share by Company (2019-2024)
3.3 Global Neuromodulation Devices Sale Price by Company
3.4 Key Manufacturers Neuromodulation Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neuromodulation Devices Product Location Distribution
3.4.2 Players Neuromodulation Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NEUROMODULATION DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Neuromodulation Devices Market Size by Geographic Region (2019-2024)
4.1.1 Global Neuromodulation Devices Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Neuromodulation Devices Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Neuromodulation Devices Market Size by Country/Region (2019-2024)
4.2.1 Global Neuromodulation Devices Annual Sales by Country/Region (2019-2024)
4.2.2 Global Neuromodulation Devices Annual Revenue by Country/Region (2019-2024)
4.3 Americas Neuromodulation Devices Sales Growth
4.4 APAC Neuromodulation Devices Sales Growth
4.5 Europe Neuromodulation Devices Sales Growth
4.6 Middle East & Africa Neuromodulation Devices Sales Growth
5 AMERICAS
5.1 Americas Neuromodulation Devices Sales by Country
5.1.1 Americas Neuromodulation Devices Sales by Country (2019-2024)
5.1.2 Americas Neuromodulation Devices Revenue by Country (2019-2024)
5.2 Americas Neuromodulation Devices Sales by Type
5.3 Americas Neuromodulation Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuromodulation Devices Sales by Region
6.1.1 APAC Neuromodulation Devices Sales by Region (2019-2024)
6.1.2 APAC Neuromodulation Devices Revenue by Region (2019-2024)
6.2 APAC Neuromodulation Devices Sales by Type
6.3 APAC Neuromodulation Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neuromodulation Devices by Country
7.1.1 Europe Neuromodulation Devices Sales by Country (2019-2024)
7.1.2 Europe Neuromodulation Devices Revenue by Country (2019-2024)
7.2 Europe Neuromodulation Devices Sales by Type
7.3 Europe Neuromodulation Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuromodulation Devices by Country
8.1.1 Middle East & Africa Neuromodulation Devices Sales by Country (2019-2024)
8.1.2 Middle East & Africa Neuromodulation Devices Revenue by Country (2019-2024)
8.2 Middle East & Africa Neuromodulation Devices Sales by Type
8.3 Middle East & Africa Neuromodulation Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neuromodulation Devices
10.3 Manufacturing Process Analysis of Neuromodulation Devices
10.4 Industry Chain Structure of Neuromodulation Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neuromodulation Devices Distributors
11.3 Neuromodulation Devices Customer
12 WORLD FORECAST REVIEW FOR NEUROMODULATION DEVICES BY GEOGRAPHIC REGION
12.1 Global Neuromodulation Devices Market Size Forecast by Region
12.1.1 Global Neuromodulation Devices Forecast by Region (2025-2030)
12.1.2 Global Neuromodulation Devices Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neuromodulation Devices Forecast by Type
12.7 Global Neuromodulation Devices Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Neuromodulation Devices Product Portfolios and Specifications
13.1.3 Medtronic Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Neuromodulation Devices Product Portfolios and Specifications
13.2.3 Boston Scientific Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Neuromodulation Devices Product Portfolios and Specifications
13.3.3 Abbott Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 LivaNova
13.4.1 LivaNova Company Information
13.4.2 LivaNova Neuromodulation Devices Product Portfolios and Specifications
13.4.3 LivaNova Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 LivaNova Main Business Overview
13.4.5 LivaNova Latest Developments
13.5 Nevro
13.5.1 Nevro Company Information
13.5.2 Nevro Neuromodulation Devices Product Portfolios and Specifications
13.5.3 Nevro Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Nevro Main Business Overview
13.5.5 Nevro Latest Developments
13.6 NeuroPace
13.6.1 NeuroPace Company Information
13.6.2 NeuroPace Neuromodulation Devices Product Portfolios and Specifications
13.6.3 NeuroPace Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 NeuroPace Main Business Overview
13.6.5 NeuroPace Latest Developments
13.7 Beijing Pins
13.7.1 Beijing Pins Company Information
13.7.2 Beijing Pins Neuromodulation Devices Product Portfolios and Specifications
13.7.3 Beijing Pins Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Beijing Pins Main Business Overview
13.7.5 Beijing Pins Latest Developments
13.8 Synapse Biomedical
13.8.1 Synapse Biomedical Company Information
13.8.2 Synapse Biomedical Neuromodulation Devices Product Portfolios and Specifications
13.8.3 Synapse Biomedical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Synapse Biomedical Main Business Overview
13.8.5 Synapse Biomedical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neuromodulation Devices Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Neuromodulation Devices Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Deep Brain Stimulation (DBS)
Table 4. Major Players of Spinal Cord Stimulation (SCS)
Table 5. Major Players of Vagus Nerve Stimulation (VNS)
Table 6. Major Players of Sacral Nerve Stimulation (SNS)
Table 7. Major Players of Gastric Electrical Stimulation (GES)
Table 8. Global Neuromodulation Devices Sales by Type (2019-2024) & (K Units)
Table 9. Global Neuromodulation Devices Sales Market Share by Type (2019-2024)
Table 10. Global Neuromodulation Devices Revenue by Type (2019-2024) & ($ million)
Table 11. Global Neuromodulation Devices Revenue Market Share by Type (2019-2024)
Table 12. Global Neuromodulation Devices Sale Price by Type (2019-2024) & (USD/Unit)
Table 13. Global Neuromodulation Devices Sales by Application (2019-2024) & (K Units)
Table 14. Global Neuromodulation Devices Sales Market Share by Application (2019-2024)
Table 15. Global Neuromodulation Devices Revenue by Application (2019-2024)
Table 16. Global Neuromodulation Devices Revenue Market Share by Application (2019-2024)
Table 17. Global Neuromodulation Devices Sale Price by Application (2019-2024) & (USD/Unit)
Table 18. Global Neuromodulation Devices Sales by Company (2019-2024) & (K Units)
Table 19. Global Neuromodulation Devices Sales Market Share by Company (2019-2024)
Table 20. Global Neuromodulation Devices Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Neuromodulation Devices Revenue Market Share by Company (2019-2024)
Table 22. Global Neuromodulation Devices Sale Price by Company (2019-2024) & (USD/Unit)
Table 23. Key Manufacturers Neuromodulation Devices Producing Area Distribution and Sales Area
Table 24. Players Neuromodulation Devices Products Offered
Table 25. Neuromodulation Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Neuromodulation Devices Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Neuromodulation Devices Sales Market Share Geographic Region (2019-2024)
Table 30. Global Neuromodulation Devices Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Neuromodulation Devices Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Neuromodulation Devices Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Neuromodulation Devices Sales Market Share by Country/Region (2019-2024)
Table 34. Global Neuromodulation Devices Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Neuromodulation Devices Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Neuromodulation Devices Sales by Country (2019-2024) & (K Units)
Table 37. Americas Neuromodulation Devices Sales Market Share by Country (2019-2024)
Table 38. Americas Neuromodulation Devices Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Neuromodulation Devices Revenue Market Share by Country (2019-2024)
Table 40. Americas Neuromodulation Devices Sales by Type (2019-2024) & (K Units)
Table 41. Americas Neuromodulation Devices Sales by Application (2019-2024) & (K Units)
Table 42. APAC Neuromodulation Devices Sales by Region (2019-2024) & (K Units)
Table 43. APAC Neuromodulation Devices Sales Market Share by Region (2019-2024)
Table 44. APAC Neuromodulation Devices Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Neuromodulation Devices Revenue Market Share by Region (2019-2024)
Table 46. APAC Neuromodulation Devices Sales by Type (2019-2024) & (K Units)
Table 47. APAC Neuromodulation Devices Sales by Application (2019-2024) & (K Units)
Table 48. Europe Neuromodulation Devices Sales by Country (2019-2024) & (K Units)
Table 49. Europe Neuromodulation Devices Sales Market Share by Country (2019-2024)
Table 50. Europe Neuromodulation Devices Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Neuromodulation Devices Revenue Market Share by Country (2019-2024)
Table 52. Europe Neuromodulation Devices Sales by Type (2019-2024) & (K Units)
Table 53. Europe Neuromodulation Devices Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa Neuromodulation Devices Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa Neuromodulation Devices Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Neuromodulation Devices Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Neuromodulation Devices Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Neuromodulation Devices Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa Neuromodulation Devices Sales by Application (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Neuromodulation Devices
Table 61. Key Market Challenges & Risks of Neuromodulation Devices
Table 62. Key Industry Trends of Neuromodulation Devices
Table 63. Neuromodulation Devices Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Neuromodulation Devices Distributors List
Table 66. Neuromodulation Devices Customer List
Table 67. Global Neuromodulation Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global Neuromodulation Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Neuromodulation Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas Neuromodulation Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Neuromodulation Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC Neuromodulation Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Neuromodulation Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe Neuromodulation Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Neuromodulation Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa Neuromodulation Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Neuromodulation Devices Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global Neuromodulation Devices Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Neuromodulation Devices Sales Forecast by Application (2025-2030) & (K Units)
Table 80. Global Neuromodulation Devices Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Medtronic Basic Information, Neuromodulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 82. Medtronic Neuromodulation Devices Product Portfolios and Specifications
Table 83. Medtronic Neuromodulation Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Medtronic Main Business
Table 85. Medtronic Latest Developments
Table 86. Boston Scientific Basic Information, Neuromodulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 87. Boston Scientific Neuromodulation Devices Product Portfolios and Specifications
Table 88. Boston Scientific Neuromodulation Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Boston Scientific Main Business
Table 90. Boston Scientific Latest Developments
Table 91. Abbott Basic Information, Neuromodulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 92. Abbott Neuromodulation Devices Product Portfolios and Specifications
Table 93. Abbott Neuromodulation Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Abbott Main Business
Table 95. Abbott Latest Developments
Table 96. LivaNova Basic Information, Neuromodulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 97. LivaNova Neuromodulation Devices Product Portfolios and Specifications
Table 98. LivaNova Neuromodulation Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. LivaNova Main Business
Table 100. LivaNova Latest Developments
Table 101. Nevro Basic Information, Neuromodulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 102. Nevro Neuromodulation Devices Product Portfolios and Specifications
Table 103. Nevro Neuromodulation Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Nevro Main Business
Table 105. Nevro Latest Developments
Table 106. NeuroPace Basic Information, Neuromodulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 107. NeuroPace Neuromodulation Devices Product Portfolios and Specifications
Table 108. NeuroPace Neuromodulation Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. NeuroPace Main Business
Table 110. NeuroPace Latest Developments
Table 111. Beijing Pins Basic Information, Neuromodulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 112. Beijing Pins Neuromodulation Devices Product Portfolios and Specifications
Table 113. Beijing Pins Neuromodulation Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Beijing Pins Main Business
Table 115. Beijing Pins Latest Developments
Table 116. Synapse Biomedical Basic Information, Neuromodulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 117. Synapse Biomedical Neuromodulation Devices Product Portfolios and Specifications
Table 118. Synapse Biomedical Neuromodulation Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Synapse Biomedical Main Business
Table 120. Synapse Biomedical Latest Developments
Table 1. Neuromodulation Devices Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Neuromodulation Devices Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Deep Brain Stimulation (DBS)
Table 4. Major Players of Spinal Cord Stimulation (SCS)
Table 5. Major Players of Vagus Nerve Stimulation (VNS)
Table 6. Major Players of Sacral Nerve Stimulation (SNS)
Table 7. Major Players of Gastric Electrical Stimulation (GES)
Table 8. Global Neuromodulation Devices Sales by Type (2019-2024) & (K Units)
Table 9. Global Neuromodulation Devices Sales Market Share by Type (2019-2024)
Table 10. Global Neuromodulation Devices Revenue by Type (2019-2024) & ($ million)
Table 11. Global Neuromodulation Devices Revenue Market Share by Type (2019-2024)
Table 12. Global Neuromodulation Devices Sale Price by Type (2019-2024) & (USD/Unit)
Table 13. Global Neuromodulation Devices Sales by Application (2019-2024) & (K Units)
Table 14. Global Neuromodulation Devices Sales Market Share by Application (2019-2024)
Table 15. Global Neuromodulation Devices Revenue by Application (2019-2024)
Table 16. Global Neuromodulation Devices Revenue Market Share by Application (2019-2024)
Table 17. Global Neuromodulation Devices Sale Price by Application (2019-2024) & (USD/Unit)
Table 18. Global Neuromodulation Devices Sales by Company (2019-2024) & (K Units)
Table 19. Global Neuromodulation Devices Sales Market Share by Company (2019-2024)
Table 20. Global Neuromodulation Devices Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Neuromodulation Devices Revenue Market Share by Company (2019-2024)
Table 22. Global Neuromodulation Devices Sale Price by Company (2019-2024) & (USD/Unit)
Table 23. Key Manufacturers Neuromodulation Devices Producing Area Distribution and Sales Area
Table 24. Players Neuromodulation Devices Products Offered
Table 25. Neuromodulation Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Neuromodulation Devices Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Neuromodulation Devices Sales Market Share Geographic Region (2019-2024)
Table 30. Global Neuromodulation Devices Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Neuromodulation Devices Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Neuromodulation Devices Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Neuromodulation Devices Sales Market Share by Country/Region (2019-2024)
Table 34. Global Neuromodulation Devices Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Neuromodulation Devices Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Neuromodulation Devices Sales by Country (2019-2024) & (K Units)
Table 37. Americas Neuromodulation Devices Sales Market Share by Country (2019-2024)
Table 38. Americas Neuromodulation Devices Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Neuromodulation Devices Revenue Market Share by Country (2019-2024)
Table 40. Americas Neuromodulation Devices Sales by Type (2019-2024) & (K Units)
Table 41. Americas Neuromodulation Devices Sales by Application (2019-2024) & (K Units)
Table 42. APAC Neuromodulation Devices Sales by Region (2019-2024) & (K Units)
Table 43. APAC Neuromodulation Devices Sales Market Share by Region (2019-2024)
Table 44. APAC Neuromodulation Devices Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Neuromodulation Devices Revenue Market Share by Region (2019-2024)
Table 46. APAC Neuromodulation Devices Sales by Type (2019-2024) & (K Units)
Table 47. APAC Neuromodulation Devices Sales by Application (2019-2024) & (K Units)
Table 48. Europe Neuromodulation Devices Sales by Country (2019-2024) & (K Units)
Table 49. Europe Neuromodulation Devices Sales Market Share by Country (2019-2024)
Table 50. Europe Neuromodulation Devices Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Neuromodulation Devices Revenue Market Share by Country (2019-2024)
Table 52. Europe Neuromodulation Devices Sales by Type (2019-2024) & (K Units)
Table 53. Europe Neuromodulation Devices Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa Neuromodulation Devices Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa Neuromodulation Devices Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Neuromodulation Devices Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Neuromodulation Devices Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Neuromodulation Devices Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa Neuromodulation Devices Sales by Application (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Neuromodulation Devices
Table 61. Key Market Challenges & Risks of Neuromodulation Devices
Table 62. Key Industry Trends of Neuromodulation Devices
Table 63. Neuromodulation Devices Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Neuromodulation Devices Distributors List
Table 66. Neuromodulation Devices Customer List
Table 67. Global Neuromodulation Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global Neuromodulation Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Neuromodulation Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas Neuromodulation Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Neuromodulation Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC Neuromodulation Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Neuromodulation Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe Neuromodulation Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Neuromodulation Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa Neuromodulation Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Neuromodulation Devices Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global Neuromodulation Devices Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Neuromodulation Devices Sales Forecast by Application (2025-2030) & (K Units)
Table 80. Global Neuromodulation Devices Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Medtronic Basic Information, Neuromodulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 82. Medtronic Neuromodulation Devices Product Portfolios and Specifications
Table 83. Medtronic Neuromodulation Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Medtronic Main Business
Table 85. Medtronic Latest Developments
Table 86. Boston Scientific Basic Information, Neuromodulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 87. Boston Scientific Neuromodulation Devices Product Portfolios and Specifications
Table 88. Boston Scientific Neuromodulation Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Boston Scientific Main Business
Table 90. Boston Scientific Latest Developments
Table 91. Abbott Basic Information, Neuromodulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 92. Abbott Neuromodulation Devices Product Portfolios and Specifications
Table 93. Abbott Neuromodulation Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Abbott Main Business
Table 95. Abbott Latest Developments
Table 96. LivaNova Basic Information, Neuromodulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 97. LivaNova Neuromodulation Devices Product Portfolios and Specifications
Table 98. LivaNova Neuromodulation Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. LivaNova Main Business
Table 100. LivaNova Latest Developments
Table 101. Nevro Basic Information, Neuromodulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 102. Nevro Neuromodulation Devices Product Portfolios and Specifications
Table 103. Nevro Neuromodulation Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Nevro Main Business
Table 105. Nevro Latest Developments
Table 106. NeuroPace Basic Information, Neuromodulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 107. NeuroPace Neuromodulation Devices Product Portfolios and Specifications
Table 108. NeuroPace Neuromodulation Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. NeuroPace Main Business
Table 110. NeuroPace Latest Developments
Table 111. Beijing Pins Basic Information, Neuromodulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 112. Beijing Pins Neuromodulation Devices Product Portfolios and Specifications
Table 113. Beijing Pins Neuromodulation Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Beijing Pins Main Business
Table 115. Beijing Pins Latest Developments
Table 116. Synapse Biomedical Basic Information, Neuromodulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 117. Synapse Biomedical Neuromodulation Devices Product Portfolios and Specifications
Table 118. Synapse Biomedical Neuromodulation Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Synapse Biomedical Main Business
Table 120. Synapse Biomedical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Neuromodulation Devices
Figure 2. Neuromodulation Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neuromodulation Devices Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Neuromodulation Devices Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Neuromodulation Devices Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Deep Brain Stimulation (DBS)
Figure 10. Product Picture of Spinal Cord Stimulation (SCS)
Figure 11. Product Picture of Vagus Nerve Stimulation (VNS)
Figure 12. Product Picture of Sacral Nerve Stimulation (SNS)
Figure 13. Product Picture of Gastric Electrical Stimulation (GES)
Figure 14. Global Neuromodulation Devices Sales Market Share by Type in 2023
Figure 15. Global Neuromodulation Devices Revenue Market Share by Type (2019-2024)
Figure 16. Neuromodulation Devices Consumed in Pain Management
Figure 17. Global Neuromodulation Devices Market: Pain Management (2019-2024) & (K Units)
Figure 18. Neuromodulation Devices Consumed in Parkinson’s Disease
Figure 19. Global Neuromodulation Devices Market: Parkinson’s Disease (2019-2024) & (K Units)
Figure 20. Neuromodulation Devices Consumed in Urinary and Fecal Incontinence
Figure 21. Global Neuromodulation Devices Market: Urinary and Fecal Incontinence (2019-2024) & (K Units)
Figure 22. Neuromodulation Devices Consumed in Epilepsy
Figure 23. Global Neuromodulation Devices Market: Epilepsy (2019-2024) & (K Units)
Figure 24. Neuromodulation Devices Consumed in Gastroparesis
Figure 25. Global Neuromodulation Devices Market: Gastroparesis (2019-2024) & (K Units)
Figure 26. Neuromodulation Devices Consumed in Other
Figure 27. Global Neuromodulation Devices Market: Other (2019-2024) & (K Units)
Figure 28. Global Neuromodulation Devices Sales Market Share by Application (2023)
Figure 29. Global Neuromodulation Devices Revenue Market Share by Application in 2023
Figure 30. Neuromodulation Devices Sales Market by Company in 2023 (K Units)
Figure 31. Global Neuromodulation Devices Sales Market Share by Company in 2023
Figure 32. Neuromodulation Devices Revenue Market by Company in 2023 ($ Million)
Figure 33. Global Neuromodulation Devices Revenue Market Share by Company in 2023
Figure 34. Global Neuromodulation Devices Sales Market Share by Geographic Region (2019-2024)
Figure 35. Global Neuromodulation Devices Revenue Market Share by Geographic Region in 2023
Figure 36. Americas Neuromodulation Devices Sales 2019-2024 (K Units)
Figure 37. Americas Neuromodulation Devices Revenue 2019-2024 ($ Millions)
Figure 38. APAC Neuromodulation Devices Sales 2019-2024 (K Units)
Figure 39. APAC Neuromodulation Devices Revenue 2019-2024 ($ Millions)
Figure 40. Europe Neuromodulation Devices Sales 2019-2024 (K Units)
Figure 41. Europe Neuromodulation Devices Revenue 2019-2024 ($ Millions)
Figure 42. Middle East & Africa Neuromodulation Devices Sales 2019-2024 (K Units)
Figure 43. Middle East & Africa Neuromodulation Devices Revenue 2019-2024 ($ Millions)
Figure 44. Americas Neuromodulation Devices Sales Market Share by Country in 2023
Figure 45. Americas Neuromodulation Devices Revenue Market Share by Country in 2023
Figure 46. Americas Neuromodulation Devices Sales Market Share by Type (2019-2024)
Figure 47. Americas Neuromodulation Devices Sales Market Share by Application (2019-2024)
Figure 48. United States Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 49. Canada Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 50. Mexico Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 51. Brazil Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 52. APAC Neuromodulation Devices Sales Market Share by Region in 2023
Figure 53. APAC Neuromodulation Devices Revenue Market Share by Regions in 2023
Figure 54. APAC Neuromodulation Devices Sales Market Share by Type (2019-2024)
Figure 55. APAC Neuromodulation Devices Sales Market Share by Application (2019-2024)
Figure 56. China Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 57. Japan Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 58. South Korea Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 59. Southeast Asia Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 60. India Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 61. Australia Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 62. China Taiwan Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 63. Europe Neuromodulation Devices Sales Market Share by Country in 2023
Figure 64. Europe Neuromodulation Devices Revenue Market Share by Country in 2023
Figure 65. Europe Neuromodulation Devices Sales Market Share by Type (2019-2024)
Figure 66. Europe Neuromodulation Devices Sales Market Share by Application (2019-2024)
Figure 67. Germany Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 68. France Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 69. UK Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 70. Italy Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 71. Russia Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 72. Middle East & Africa Neuromodulation Devices Sales Market Share by Country in 2023
Figure 73. Middle East & Africa Neuromodulation Devices Revenue Market Share by Country in 2023
Figure 74. Middle East & Africa Neuromodulation Devices Sales Market Share by Type (2019-2024)
Figure 75. Middle East & Africa Neuromodulation Devices Sales Market Share by Application (2019-2024)
Figure 76. Egypt Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 77. South Africa Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 78. Israel Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 79. Turkey Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 80. GCC Country Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 81. Manufacturing Cost Structure Analysis of Neuromodulation Devices in 2023
Figure 82. Manufacturing Process Analysis of Neuromodulation Devices
Figure 83. Industry Chain Structure of Neuromodulation Devices
Figure 84. Channels of Distribution
Figure 85. Global Neuromodulation Devices Sales Market Forecast by Region (2025-2030)
Figure 86. Global Neuromodulation Devices Revenue Market Share Forecast by Region (2025-2030)
Figure 87. Global Neuromodulation Devices Sales Market Share Forecast by Type (2025-2030)
Figure 88. Global Neuromodulation Devices Revenue Market Share Forecast by Type (2025-2030)
Figure 89. Global Neuromodulation Devices Sales Market Share Forecast by Application (2025-2030)
Figure 90. Global Neuromodulation Devices Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Neuromodulation Devices
Figure 2. Neuromodulation Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neuromodulation Devices Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Neuromodulation Devices Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Neuromodulation Devices Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Deep Brain Stimulation (DBS)
Figure 10. Product Picture of Spinal Cord Stimulation (SCS)
Figure 11. Product Picture of Vagus Nerve Stimulation (VNS)
Figure 12. Product Picture of Sacral Nerve Stimulation (SNS)
Figure 13. Product Picture of Gastric Electrical Stimulation (GES)
Figure 14. Global Neuromodulation Devices Sales Market Share by Type in 2023
Figure 15. Global Neuromodulation Devices Revenue Market Share by Type (2019-2024)
Figure 16. Neuromodulation Devices Consumed in Pain Management
Figure 17. Global Neuromodulation Devices Market: Pain Management (2019-2024) & (K Units)
Figure 18. Neuromodulation Devices Consumed in Parkinson’s Disease
Figure 19. Global Neuromodulation Devices Market: Parkinson’s Disease (2019-2024) & (K Units)
Figure 20. Neuromodulation Devices Consumed in Urinary and Fecal Incontinence
Figure 21. Global Neuromodulation Devices Market: Urinary and Fecal Incontinence (2019-2024) & (K Units)
Figure 22. Neuromodulation Devices Consumed in Epilepsy
Figure 23. Global Neuromodulation Devices Market: Epilepsy (2019-2024) & (K Units)
Figure 24. Neuromodulation Devices Consumed in Gastroparesis
Figure 25. Global Neuromodulation Devices Market: Gastroparesis (2019-2024) & (K Units)
Figure 26. Neuromodulation Devices Consumed in Other
Figure 27. Global Neuromodulation Devices Market: Other (2019-2024) & (K Units)
Figure 28. Global Neuromodulation Devices Sales Market Share by Application (2023)
Figure 29. Global Neuromodulation Devices Revenue Market Share by Application in 2023
Figure 30. Neuromodulation Devices Sales Market by Company in 2023 (K Units)
Figure 31. Global Neuromodulation Devices Sales Market Share by Company in 2023
Figure 32. Neuromodulation Devices Revenue Market by Company in 2023 ($ Million)
Figure 33. Global Neuromodulation Devices Revenue Market Share by Company in 2023
Figure 34. Global Neuromodulation Devices Sales Market Share by Geographic Region (2019-2024)
Figure 35. Global Neuromodulation Devices Revenue Market Share by Geographic Region in 2023
Figure 36. Americas Neuromodulation Devices Sales 2019-2024 (K Units)
Figure 37. Americas Neuromodulation Devices Revenue 2019-2024 ($ Millions)
Figure 38. APAC Neuromodulation Devices Sales 2019-2024 (K Units)
Figure 39. APAC Neuromodulation Devices Revenue 2019-2024 ($ Millions)
Figure 40. Europe Neuromodulation Devices Sales 2019-2024 (K Units)
Figure 41. Europe Neuromodulation Devices Revenue 2019-2024 ($ Millions)
Figure 42. Middle East & Africa Neuromodulation Devices Sales 2019-2024 (K Units)
Figure 43. Middle East & Africa Neuromodulation Devices Revenue 2019-2024 ($ Millions)
Figure 44. Americas Neuromodulation Devices Sales Market Share by Country in 2023
Figure 45. Americas Neuromodulation Devices Revenue Market Share by Country in 2023
Figure 46. Americas Neuromodulation Devices Sales Market Share by Type (2019-2024)
Figure 47. Americas Neuromodulation Devices Sales Market Share by Application (2019-2024)
Figure 48. United States Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 49. Canada Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 50. Mexico Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 51. Brazil Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 52. APAC Neuromodulation Devices Sales Market Share by Region in 2023
Figure 53. APAC Neuromodulation Devices Revenue Market Share by Regions in 2023
Figure 54. APAC Neuromodulation Devices Sales Market Share by Type (2019-2024)
Figure 55. APAC Neuromodulation Devices Sales Market Share by Application (2019-2024)
Figure 56. China Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 57. Japan Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 58. South Korea Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 59. Southeast Asia Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 60. India Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 61. Australia Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 62. China Taiwan Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 63. Europe Neuromodulation Devices Sales Market Share by Country in 2023
Figure 64. Europe Neuromodulation Devices Revenue Market Share by Country in 2023
Figure 65. Europe Neuromodulation Devices Sales Market Share by Type (2019-2024)
Figure 66. Europe Neuromodulation Devices Sales Market Share by Application (2019-2024)
Figure 67. Germany Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 68. France Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 69. UK Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 70. Italy Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 71. Russia Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 72. Middle East & Africa Neuromodulation Devices Sales Market Share by Country in 2023
Figure 73. Middle East & Africa Neuromodulation Devices Revenue Market Share by Country in 2023
Figure 74. Middle East & Africa Neuromodulation Devices Sales Market Share by Type (2019-2024)
Figure 75. Middle East & Africa Neuromodulation Devices Sales Market Share by Application (2019-2024)
Figure 76. Egypt Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 77. South Africa Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 78. Israel Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 79. Turkey Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 80. GCC Country Neuromodulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 81. Manufacturing Cost Structure Analysis of Neuromodulation Devices in 2023
Figure 82. Manufacturing Process Analysis of Neuromodulation Devices
Figure 83. Industry Chain Structure of Neuromodulation Devices
Figure 84. Channels of Distribution
Figure 85. Global Neuromodulation Devices Sales Market Forecast by Region (2025-2030)
Figure 86. Global Neuromodulation Devices Revenue Market Share Forecast by Region (2025-2030)
Figure 87. Global Neuromodulation Devices Sales Market Share Forecast by Type (2025-2030)
Figure 88. Global Neuromodulation Devices Revenue Market Share Forecast by Type (2025-2030)
Figure 89. Global Neuromodulation Devices Sales Market Share Forecast by Application (2025-2030)
Figure 90. Global Neuromodulation Devices Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Octreotide Market Growth 2025-2031
US$ 3,660.00
January 2025
103 pages
Global Array Spinal System Market Growth 2024-2030
US$ 3,660.00
May 2024
109 pages
Global Minimally Invasive Surgery Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
109 pages
Global Infection Control Bag Market Growth 2023-2029
US$ 3,660.00
March 2023
95 pages
Global APOL1 Mediated Kidney Disease Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
October 2024
85 pages
